Voyager Therapeutics, Inc.

VYGR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $393.1M

Liabilities Breakdown FY2024

Total Liabilities: $93.3M